ChAdOx1 nCoV-19 Vaccine Efficacy against the B.1.351 Variant
N Engl J Med
.
2021 Aug 5;385(6):571.
doi: 10.1056/NEJMc2110093.
Epub 2021 Jul 21.
Authors
Frank Struyf
1
,
Jerald Sadoff
2
,
Macaya Douoguih
2
Affiliations
1
Janssen Research and Development, Beerse, Belgium fstruyf@its.jnj.com.
2
Janssen Vaccines and Prevention, Leiden, the Netherlands.
PMID:
34289270
DOI:
10.1056/NEJMc2110093
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
ChAdOx1 nCoV-19
Humans
SARS-CoV-2
Vaccines*
Substances
COVID-19 Vaccines
Vaccines
ChAdOx1 nCoV-19